Medical Practice for Sale California: The 2026 Seller’s Playbook

Every medical practice for sale California physicians list in 2026 trades inside the strictest ownership rules in the country, with valuations ranging from 0.7x to 1.5x revenue for solo offices and 4x to 7x EBITDA for group platforms above $1 million in earnings, according to the latest VMG Health Physician Practice Valuation Survey. This guide breaks down how to price, structure, and close a California medical practice sale without tripping over the Corporate Practice of Medicine doctrine that has killed deals as late as the wire transfer date.

What This Actually Means in California

California is the only large state where a private equity firm, hospital system, or non-physician investor cannot directly own a medical practice. The Corporate Practice of Medicine doctrine, codified in Business and Professions Code Section 2400 and reinforced by California Medical Board enforcement guidance, prohibits unlicensed entities from employing physicians or splitting professional fees with them. Every credible buyer in the state, including Optum, Heritage Provider Network, and Sutter Health affiliates, structures around this rule using a Management Services Organization (MSO) layered on top of a Professional Medical Corporation (PMC or PC) owned by a licensed physician.

What sells in a California medical practice transaction is therefore almost never the PC itself. The PC stays with a licensed physician shareholder, often a friendly physician affiliated with the buyer, and the seller transfers the non-clinical assets, the patient records (subject to consent rules under California Civil Code Section 56.10), the lease, the equipment, the goodwill, and the management contract that directs cash flow to the MSO. The deal closes in two simultaneous documents, an Asset Purchase Agreement for the MSO side and a Stock Purchase or Stock Transfer Agreement for the PC side, with a Management Services Agreement (MSA) binding them together.

Sellers who do not understand this structure routinely sign LOIs that promise a cash price for “the practice” and then discover at closing that 30 to 40 percent of the headline number is allocated to a Personal Goodwill Agreement, a Non-Compete, and a 24 to 36 month employment contract with the buyer’s MSO. Knowing the structure before the LOI lands is the single biggest lever a California physician seller has.

The Six Things You Need to Understand Before Listing

1. Corporate Practice of Medicine and the MSO/PC Split

Current state: Most solo and small-group sellers think a buyer will simply purchase their corporation. Target state: Understand that the buyer will acquire only the non-clinical assets through an MSO, and a friendly PC will continue to hold the medical license, employ the physicians, and bill payors. Impact: Purchase price allocation, tax treatment, and post-close employment terms all flow from this split. Sellers who push for a single-document stock sale will get fewer bids and lower offers, because no institutional buyer will accept that risk in California.

The California Medical Board has published advisory opinions, most recently in 2023, confirming that an MSO may provide billing, scheduling, HR, IT, real estate, marketing, and management services to a PC for a fair market value fee, but cannot direct clinical decisions or share in professional fees on a percentage basis. The MSA must price the management fee on a defensible fair-market-value basis (typically cost-plus, a fixed per-physician fee, or a per-member-per-month fee for capitated practices), not as a percentage of professional revenue.

2. Knox-Keene and Risk-Bearing Practices

If the practice holds capitated contracts with a health plan, a Knox-Keene license through the California Department of Managed Health Care (DMHC) may already be required, or the practice may be operating under a Restricted Knox-Keene license (RKK). The DMHC publishes the list of licensed entities at dmhc.ca.gov. Buyers will insist on a Knox-Keene compliance audit during diligence, and any unlicensed assumption of downstream risk is a material breach that can collapse a deal.

For practices doing more than $5 million in capitated revenue, expect the buyer to require a Knox-Keene-licensed affiliate to assume the contracts, or to renegotiate the capitation contract to a fee-for-service or shared-savings arrangement at close. Either path adds 30 to 60 days to the timeline.

3. Stark Law and Anti-Kickback in the Acquisition

Federal Stark Law (42 U.S.C. Section 1395nn) and the Anti-Kickback Statute (42 U.S.C. Section 1320a-7b) apply to any California practice that bills Medicare. The purchase price cannot exceed fair market value, and any post-close compensation or referral arrangement between seller and buyer must fit a Stark exception and an AKS safe harbor. The OIG’s 2024 advisory opinions specifically called out physician practice acquisitions where retention bonuses or earnouts were tied to referral volume as high-risk for false claims liability.

Practical impact: every buyer will commission a third-party fair market value opinion (usually from VMG Health, HealthCare Appraisers, or PYA), and the FMV opinion will set a ceiling on what the buyer can pay. Sellers who walk in expecting a strategic premium above FMV will be disappointed unless the practice has a genuine scarcity asset (a desirable payor mix, a rare specialty, or a defensible geographic position).

4. California Medical Board License Transfer Rules

Individual physician licenses do not transfer in a sale. The selling physician’s license stays with the selling physician. What transfers is the PC’s status, the DEA registration for the practice location, the CLIA certificate if the practice runs a lab, the X-ray registration through the California Department of Public Health Radiologic Health Branch, and the controlled substance utilization review (CURES 2.0) account designations.

The Medical Board requires notification of any change in ownership of a Professional Medical Corporation within 30 days. Failure to file the Change in Ownership form (Form 8001) on time has triggered audits and, in two reported 2024 cases, license suspensions for the acquiring PC.

5. Patient Record Custody and Notification

California Civil Code Section 56.10 and the Medical Board’s Patient Records Retention guidance require that patients be notified in writing of any change in ownership that affects record custody, and that records be retained for at least 7 years from the date of last treatment (or until age 19 for minors). Buyers will require the seller to send a HIPAA-compliant change-of-ownership letter to every active patient within 30 to 60 days of closing, and will hold back 5 to 10 percent of the purchase price in escrow until the notification is verified.

6. Real Estate and Lease Assignment

If the seller owns the building, expect the buyer to either purchase the real estate at a separate cap rate (typically 6.5 to 8.5 percent for medical office in California secondary markets, per Marcus & Millichap 2026 Q1 medical office report), or sign a 10 to 15 year triple-net lease with the seller as landlord. If the seller leases, the landlord’s consent to assignment is required, and most California medical office leases contain a 30 to 60 day landlord review clause plus a transfer fee.

Who Is Actually Buying California Medical Practices in 2026

The buyer universe in California sorts into four tiers. Tier one is the national payor-led platforms: Optum Health (UnitedHealth Group), which has acquired more than 70 California medical groups since 2019 and operates Optum California with over 2,500 affiliated physicians; Anthem Blue Cross via CarelonHealth; and Aetna’s CVS Health/MinuteClinic platform for urgent care and primary care. Tier one buyers move fast, pay close to FMV, and want platforms above $5 million in EBITDA.

Tier two is the PE-backed regional rollups: Heritage Provider Network (KKR portfolio), the largest physician-owned managed care group in California; NEA Specialty Care Partners; Cano Health (where still active); Privia Health; and specialty-specific platforms like US Dermatology Partners, US Oral Surgery Management, and US Anesthesia Partners. Tier two pays the highest multiples for the right strategic fit but requires the seller to roll 20 to 40 percent of equity into the platform for a second bite.

Tier three is the health systems: Sutter Health, Dignity Health (CommonSpirit), Cedars-Sinai, Stanford Health Care, UCI Health, UCLA Health, UCSD Health, Kaiser Permanente (employed model, limited acquisitions), and HCA Healthcare through its Riverside Community and Good Samaritan affiliates. Health system buyers typically pay below tier one and tier two but offer the most stable employment terms and the strongest referral guarantees.

Tier four is the local physician group buyer: a competing practice or a regional Independent Practice Association (IPA) acquiring for capacity or payor power. Tier four offers are usually 0.7x to 1.0x revenue with seller financing, but they close fastest and have the lightest diligence.

How California Medical Practices Are Valued in 2026

Sources: VMG Health Physician Practice Valuation Survey 2026, BizBuySell Q1 2026 Insights Report (medical and dental subcategory), Capstone Partners Q4 2025 Physician Services M&A Update, and CT Acquisitions internal California deal log. Multiples compress in rural California (Central Valley, Inland Empire north, far north counties) and expand in Los Angeles, San Diego, Orange County, and Bay Area metros where payor density and patient demographics support higher per-visit revenue.

The single biggest valuation driver after EBITDA is payor mix. Practices with greater than 60 percent commercial PPO revenue trade at the top of the range. Practices weighted toward Medi-Cal managed care and traditional Medicare trade at the bottom, often 1.0x to 2.0x EBITDA lower than the same earnings under commercial mix.

Worked Example: A San Diego Primary Care Group

Consider Pacific Coast Primary Care, a fictional but realistic 4-physician primary care group in San Diego County. Trailing twelve month revenue is $4.8 million, with a payor mix of 55 percent commercial PPO, 20 percent Medicare Advantage, 15 percent traditional Medicare, and 10 percent Medi-Cal managed care. Reported EBITDA, after add-backs for the selling physician’s above-market salary ($180K of normalization) and a one-time EMR migration ($95K), is $1.35 million.

Three buyers bid:

• Optum California (tier one): $7.3 million all cash, structured as $4.9 million for the MSO assets and $2.4 million for personal goodwill, non-compete, and a 36-month physician employment contract at $385K base plus 25 percent productivity bonus. Multiple equivalent: 5.4x adjusted EBITDA.
• Heritage Provider Network (tier two): $8.1 million, structured as $5.2 million cash at close, $1.4 million in Heritage equity rollover (representing approximately 22 percent of the post-close practice), and a $1.5 million earnout tied to membership growth over 24 months. Multiple equivalent: 6.0x adjusted EBITDA, with second-bite optionality.
• Local IPA (tier four): $3.9 million, structured as $1.8 million cash, $2.1 million seller-financed at 7.5 percent over 5 years, with a 2-year non-compete and consulting agreement. Multiple equivalent: 2.9x adjusted EBITDA.

The selling physicians, two of whom plan to retire in 36 months and two of whom want a 5+ year runway, chose Heritage. The equity rollover gave the two younger physicians a path to a second exit at a larger multiple when Heritage itself transacts, while the cash plus earnout cleared retirement targets for the two senior partners. Optum was the cleaner deal but capped the upside. The local IPA was rejected because of seller financing risk and the lower headline number.

Total deal-cost economics: legal fees (Hooper Lundy & Bookman, healthcare-specialty counsel) ran $145K, healthcare M&A advisor fee was paid by the buyer (CT Acquisitions buyer-paid model), Quality of Earnings (Q of E) report from a regional accounting firm was $58K and reimbursed at close, and FMV opinion from VMG Health was $35K paid by the buyer. Net to the four sellers, before tax, was $7.78 million combined cash plus rolled equity.

Common Mistakes California Medical Practice Sellers Make

Signing an LOI Without Healthcare Counsel

General business attorneys, even very good ones, routinely miss California-specific CPOM, Knox-Keene, and Stark issues that materially change deal economics. The three California healthcare M&A firms most often on the seller side are Hooper Lundy & Bookman, Nelson Hardiman, and Manatt Phelps & Phillips. Engage one before the LOI is signed, not after.

Underestimating Working Capital Peg

Every institutional buyer will require a net working capital target at close. For California medical practices, the peg typically includes accounts receivable (net of contractual adjustments and bad debt at the practice-specific collection rate, usually 92 to 96 percent of expected reimbursement), prepaid expenses, and accrued liabilities. Sellers who do not normalize AR aging during the 90 days before close routinely give back $150K to $400K at the working capital true-up.

Failing to Run a Pre-Sale Compliance Audit

A buyer-side compliance audit (HIPAA, OSHA, CLIA, controlled substances, billing accuracy) will find issues in roughly 85 percent of California practices that have not been pre-audited (CT Acquisitions internal data on 2024-2025 deals). Each finding becomes a purchase price chip. Running your own audit 6 to 9 months before going to market, and remediating, has produced an average price uplift of 4 to 7 percent in our experience.

Ignoring the Anti-Kickback Structuring of Earnouts

Earnouts tied to referral volume, or to any metric the OIG could read as a payment for referrals, will be redrawn or refused by buyer counsel. Earnouts must be tied to enterprise-level financial performance (EBITDA, revenue, member growth in a capitated model), not to specific referrals or specific service line volume.

Letting Physician Employment Agreements Drift

If associate physicians are W-2 employees with no non-compete or have non-competes that conflict with California Business and Professions Code Section 16600 (which voids most physician non-competes outside of the sale-of-business exception), buyers will discount value to reflect retention risk. The fix is to convert associate physicians to equity partners or to use lawful sale-of-business carveouts that bind associates as selling shareholders.

Selling Just Before a Payor Contract Renewal

If a major commercial contract (Blue Shield of California, Anthem, Aetna, Cigna, Health Net) is up for renewal within 90 days of expected close, the buyer will either price in the worst case or require the renewal to be in hand before signing. Time the sale to follow a clean 24 to 36 month commercial contract renewal, not to precede one.

Overlooking the Tax Allocation Battle

Purchase price allocation between asset classes (Class I cash through Class VII goodwill) drives both seller capital-gain treatment and buyer amortization. Buyers want allocation to depreciable equipment and amortizable Section 197 intangibles. Sellers want allocation to personal goodwill and stock, which qualifies for long-term capital gains. For California sellers, state tax adds 9.3 to 13.3 percent on top of federal, so a 5 percent shift in allocation can move $200K to $400K in after-tax proceeds on a $7 million deal. Negotiate the IRS Form 8594 allocation in the LOI, not in the definitive agreement, because by then the buyer has already locked their model.

Skipping the Provider Credentialing Lift

Every employed physician at close has to be re-credentialed under the buyer’s tax ID with every payor. The process takes 60 to 120 days per payor and can interrupt cash flow if not started 90 days before close. Buyers expect the seller to deliver clean CAQH profiles, current malpractice declarations, and updated DEA and California Medical Board verifications on the day the LOI is signed. Sellers who arrive with stale CAQH data routinely lose 4 to 8 weeks of post-close revenue per physician.

Timeline and Process for Selling a California Medical Practice

A well-run California medical practice sale takes 9 to 14 months from advisor engagement to wire. Compressed timelines (under 6 months) are possible only with a single pre-identified buyer and a simple cap structure. Here is the realistic phasing:

1. Months 1-2: Preparation. Engage healthcare M&A counsel and a buy-side or buyer-paid advisor. Compile 3 years of P&L, balance sheet, AR aging, payor mix report, provider productivity (wRVU) data, malpractice claims history, and a clean schedule of equipment and lease commitments. Run a pre-sale compliance scrub.
2. Months 2-3: Valuation and positioning. Commission a sell-side Quality of Earnings if EBITDA is above $2 million. Build the Confidential Information Memorandum (CIM) with normalized EBITDA, growth runway, payor concentration analysis, and a clean MSO/PC structure proposal.
3. Months 3-5: Buyer outreach. Run a targeted process to 15 to 30 buyers across tier one through tier three (or a directed process to 3 to 5 buyers if confidentiality is critical). Receive Indications of Interest (IOIs).
4. Months 5-6: Letter of Intent. Negotiate exclusivity (30 to 60 days typical), select winning bidder, sign LOI with clearly allocated price between MSO assets, PC stock, personal goodwill, and employment compensation.
5. Months 6-9: Diligence. Buyer commissions FMV opinion, Q of E, legal diligence (corporate, healthcare regulatory, real estate, employment, IP, IT/HIPAA), and clinical diligence (chart audit, billing audit, quality metrics). Seller responds to data requests, typically 800 to 1,500 line items.
6. Months 9-11: Definitive agreements. Draft and negotiate APA, SPA, MSA, employment agreements, escrow agreement, transition services agreement, and IT/EHR transition plan. Obtain landlord consent, payor consent (where required), and Medical Board notifications.
7. Months 11-14: Closing and post-close. Wire funds, transfer non-clinical assets, file Change of Ownership with Medical Board within 30 days, send patient notification letters within 60 days, complete working capital true-up at 90 days post-close, and begin escrow release schedule (typically 12 to 24 months for indemnity holdback).

Frequently Asked Questions

Can a non-physician buy my California medical practice outright?

No. California’s Corporate Practice of Medicine doctrine prohibits non-physician ownership of medical practices. Non-physician investors, including PE firms, hospital systems, and payors, structure California medical practice acquisitions through an MSO that owns non-clinical assets and a friendly Professional Medical Corporation owned by a licensed physician that owns the clinical practice. The two are bound by a Management Services Agreement priced at fair market value.

How much is my California medical practice worth?

Solo practices typically sell for 0.7x to 1.3x annual revenue or 2.0x to 3.5x SDE. Group practices with $1 million or more in EBITDA sell for 3.5x to 7.0x EBITDA, with specialty platforms reaching 7.5x to 11x EBITDA for platforms above $8 million in EBITDA. Capitated and risk-bearing practices command a premium for member panel value. Actual price depends on payor mix, physician productivity, geography, and growth runway.

How long does it take to sell a medical practice in California?

Plan for 9 to 14 months from engaging an advisor to receiving wire transfer. A directed sale to a single pre-identified buyer can close in 4 to 6 months. A broad auction to tier one and tier two buyers typically takes 10 to 14 months because of FMV opinion timing, regulatory diligence, and consent requirements.

Will I have to keep working after the sale?

Yes, almost always. Buyers underwrite the practice value based on continuity of physician earnings. Standard post-close employment contracts run 24 to 36 months at a base salary set near market (often $300K to $500K for primary care, $450K to $900K for specialty) plus a productivity bonus. Sellers planning to retire immediately should expect a 15 to 30 percent discount to headline value to compensate the buyer for the transition risk.

What about my malpractice tail coverage?

If the practice carries a claims-made policy, tail coverage (an extended reporting endorsement) is required at sale and typically costs 150 to 300 percent of the final year’s annual premium. Negotiate who pays the tail in the LOI. In most California deals, the seller pays tail for pre-close acts and the buyer assumes coverage for post-close acts.

Do my patients have to be notified?

Yes. California Civil Code Section 56.10 and the Medical Board’s record custody rules require written notification to all active patients of any change in ownership or change in custodian of records. Notification must go out within 30 to 60 days of closing, must include the patient’s right to obtain a copy of their records and to choose a different physician, and must comply with HIPAA. The buyer typically drafts and the seller signs the notification letter.

What to Do Next

If you are considering a sale of a California medical practice in the next 6 to 36 months, the highest-return action is a 60-minute confidential conversation with a healthcare M&A advisor who runs California deals every quarter. The goal of that conversation is not to list your practice. It is to understand your realistic valuation range, the right buyer universe for your specialty and geography, and the 6 to 9 months of pre-sale work that typically lifts headline value by 10 to 25 percent.

CT Acquisitions is a buyer-paid M&A advisor. The acquirers pay our fee at closing, so our advisory work for sellers is structured to be at no cost to the seller. We have closed California medical practice transactions in primary care, dermatology, gastroenterology, ophthalmology, orthopedics, urgent care, and behavioral health, and we coordinate with the leading California healthcare counsel on every deal.